Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cronos Group Inc (CRON) vs Mondaycom Ltd (MNDY) Price & Performance

Cronos Group IncTrade
Mondaycom LtdTrade

Price performance (Past 24H)

Key statistics

Cronos Group Inc vs Mondaycom Ltd — how do they compare? Cronos Group Inc trades at $3.12 (market cap $1.14B), while Mondaycom Ltd trades at $84.67 (market cap $3.70B). The key difference: Mondaycom Ltd is far larger — about 3.2× Cronos Group Inc's market cap, and Cronos Group Inc is trading nearer its 52-week high, Mondaycom Ltd nearer its low. Which is the better fit depends on your goals.

CRONMNDY
Market Cap
$1.14B$3.70B
Sector
HealthTechnology
52-Week High
$3.27$219.15
52-Week Low
$2.30$58.81
Enterprise Value
$341.13M$2.86B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cronos Group Inc

CRON trades at $3.00, down 3.23% today, with a bullish technical signal from moving averages. The company showed strong Q2 2026 performance with 58% YoY revenue growth and earnings beat, though recent quarters were mixed. Valuation metrics include P/E of 16.21 and P/S of 6.55, while profitability improved with 45.86% gross margin. Analyst consensus is mixed with 20% buy, 60% hold ratings.

Outlook remains positive due to international expansion and strong product positioning, particularly in Canada and Europe. Key risks include competitive pressures and cash flow volatility from aggressive investing. The stock presents growth potential but requires monitoring of execution and market conditions.

Mondaycom Ltd

Monday.com (MNDY) trades at $84.4, down 4.76% amid mixed signals. The stock shows strong fundamentals with Q2 2026 EPS of $1.48 beating estimates by 33%, revenue growth of 22% year-over-year, and a high gross margin of 88.74%. However, weak Q3 revenue guidance has triggered a sell-off. Technical indicators are neutral with support at $83 and resistance at $89. Analyst consensus remains bullish with a $113.38 price target, but near-term volatility persists due to growth concerns.

The outlook is cautiously optimistic given solid earnings beats and AI product traction, but investor sentiment is tempered by slowing revenue guidance. Key risks include SaaS sector pressures and execution challenges in shifting to enterprise AI. Upside potential exists if the company exceeds Q3 expectations, though volatility may continue until growth reaccelerates.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Cronos Group Inc

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.

Read more on CRON

About Mondaycom Ltd

Monday.com Ltd. is a cloud-based software company providing a Work OS (Operating System) that enables organizations to manage projects, processes, and daily work. The platform is highly customizable, enabling teams to build tailored applications and workflows for a range of use cases, from marketing and sales to software development and HR. monday.com serves clients across numerous industries, aiming to improve transparency, collaboration, and efficiency across the entire enterprise.

Read more on MNDY